Superficial Radiation Therapy | Sensus | Orlando
Our Orlando dermatology practice is the FIRST IN CENTRAL FLORIDA to offer an alternative to surgical procedures, for specific types on non-melanoma skin cancer using a new cutting-edge technology, called the SRT 100™.
Did You Know?
According to current estimates, 40-50% of Americans who live to age 65 will have skin cancer at least once.*
The two most common kinds of skin cancer are basal cell cancer and squamous cell cancer. Basal cell cancer is a slow-growing cancer that seldom spreads to other parts of the body. Squamous cell cancer also rarely spreads, but it does so more often than basal cell cancer. However, it is important that skin cancers be found and treated early because they can invade and destroy nearby tissue.*
NOTE: If your physician has diagnosed you with non-melanoma skin cancer, Superficial Radiation Therapy (SRT) is a safe and effective non-surgical option for your treatment.
* Source: National Cancer Institute.
How Does Radiation Work?*
Radiation is a very important tool in the fight against cancer. When radiation interacts with cancerous cell, it alters the cell's DNA (or genetic make-up) and its ability to reproduce, which ultimately leads to cell death in the cancerous tumor.
What is SRT?
Superficial Radiation Therapy (SRT), a low-energy radiotherapy that penetrates only a short distance below the surface of the skin, is a highly effective, painless, and cosmetically attractive alternative to surgery in selected cancers and patient populations. The SRT-100™ is the new and most advanced choice for Superficial Radiation Therapy available today. It is painless, and very similar to having an X-ray.
Why Choose SRT?
The SRT-100™ treats non-melanoma skin cancers that are found on the surface of the skin. It can be used for lesions on the arms, legs, back and trunk, but it is especially well suited for skin cancers of the head and neck regions-the fold in the nose, eyelids, lips, corner of the mouth, and the lining of the ear that would otherwise lead to a less than desirable cosmetic outcome. SRT is also a great treatment option for patients who are considered high risk for surgical procedures.
What to Expect
- The SRT procedure is non-surgical and does not require the use of anesthetics.
- You will be required to attend multiple sessions, depending on your doctor's recommendations.
- Tell your doctor about any medications and continue them unless your physician tells you otherwise.
- The X-ray will be directed toward the lesion by placing an applicator cone over the treated area.
- Once the treatment begins, it will take approximately 90 seconds to deliver the therapy.
- The treatment is painless, but you will notice skin redness by the end of the first week's treatment.
- Post treatment, the skin will form a protective scab. The new, healthy skin will develop underneath it.
* Source: Sensus Healthcare.
IMPORTANT: If you suspect you have skin cancer or have a biopsy proving you have been diagnosed with non-melanoma skin cancer, call our Orlando dermatology practice today at 800-827-SKIN (7546) to see if you are a candidate for Superficial Radiation Therapy.
DISCLAIMER: The information provided by this site is intended solely for educational purposes. This information is not to be used for medical diagnostic purposes and is not intended to serve as a recommendation for treatment and/or management of any medical/surgical condition. Most of all, this information should not be used in place of a physician or other qualified health provider. If you believe you have a medical condition, please contact your physician immediately.
My husband and I both had a wonderful experience at Dr. Michael Steppie's office in Kissimmee. We both had to have cell's removed and patient care was of the upmost. The staff was always asking how I felt and if I felt any pain. My whole experience was wonderful. When I was finished with surgery, they started on my husband. He also said his whole experience was very professional and we both recommend Dr. Steppie's office for our friends.
— Katherine R.